MiNDERA is developing a microneedle platform that leverages genomic science to enable a new era of skin analytics through personalized treatment decisions.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free